Photo: visualspace/Getty Images
Pete Pharma announced it is partnering with Fabrx to bring the company's pharmaceutical 3D printing technology to the compounding pharmacy market in the United States.
Fabrx's pharmaceutical 3D printing platform is used in hospitals, universities and clinical research centers.
According to the company, the M3DIMAKER 1 is Fabrx's single printhead pharmaceutical 3D printer used for research and small-batch manufacture of personalized medicine and medical devices.
M3DIMAKER 2 is a multi-printhead pharmaceutical 3D printer that is capable of rapid polypill manufacture of human and veterinary precision medicine and drug development. It is designed for higher throughput, larger-batch manufacturing of personalized medicine and medical devices.
The company also makes software that facilitates customizable 3D printing that can be used to select a 3D model, prepare 3D printing parameters and control the printers.
Pete Pharma asserts that deploying pharmaceutical 3D printing will give compounding pharmacies the ability to improve workflow efficiency by automating laborious processes and allow for greater personalization of medications, especially in areas such as pediatrics, lifestyle therapeutics, hormone replacement therapy and metabolic care.
In addition to bringing Fabrx's technology to the U.S., Pete Pharma says it launched a platform via a "pharmacy-first" business model to address the needs of pharmacies and determine success by the value and outcomes built through compounded products.
The model is designed to be accessible to independent pharmacies and lower the burden of labor and consumable waste, according to the company.
"By combining FABRX’s proven scientific expertise with Pete Pharma's commercialization strategy, we're making pharmaceutical 3D printing not just possible, but practical and scalable across the U.S. market," Dan Siddall, founder of Pete Pharma, said in a statement.
THE LARGER TREND
Other companies in the 3D printing space include Lattice Medical.
In June, Julien Payen, cofounder and CEO of Lattice Medical, sat down with MobiHealthNews for its Emerging Technologies series to discuss the company's 3D-printed breast implant that supports women recovering from mastectomy using a scaffold that gradually dissolves as the patient's own tissue regenerates.
In April, 3D printed orthopedic implant care company restor3d announced it raised $38 million.
The funds were used to launch four new 3D-printed product lines: Veritas reverse total shoulder system, total identity 3DP porous cementless total knee, Kinos modular stem total ankle system and Velora 3DP porous acetabular system.
In 2023, Dr. Abdullah Ghazi, a urology consultant specializing in neurourology and genitourinary reconstruction and head of academic and training affairs at King Faisal Specialist Hospital and Research Center in Saudi Arabia, contributed an article to MobiHealthNews about how simulation learning, such as augmented reality and 3D printing, prepares future health professionals for real-world scenarios.
